|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 480.25 USD | -1.06% |
|
-9.05% | +5.93% |
| 13/07 | UBS Adjusts Vertex Pharmaceuticals Price Target to $585 From $545, Maintains Buy Rating | MT |
| 09/07 | RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 12TCr | |||||
| 1,06000Cr | |||||
| 62TCr | |||||
| 44TCr | |||||
| 33TCr | |||||
| 28TCr |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
